News|Articles|August 1, 2023
Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia
Author(s)Mikart
Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
2
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
3
European Parliament Revamps Pharmaceutical Policy Framework
4
Optimizing Pharmaceutical Manufacturing Efficiency
5
